Trials / Completed
CompletedNCT04455776
Safety Evaluation of Propofol Sedation for Magnetic Resonance Imaging in Pediatric Patients
Incidence of Adverse Events During Propofol Sedation for Magnetic Resonance Imaging in Pediatric Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 99 (actual)
- Sponsor
- Brugmann University Hospital · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- —
Summary
Propofol is often used for sedation in children undergoing magnetic resonance imaging. The investigators will perform a chart review of 4 month of activity (about 100 cases) and review the incidence and severity of adverse events of this sedation technique.
Detailed description
Magnetic resonance imaging in children, especially under 6 years of age, is often performed under sedation. Propofol is a common drug used in this settings. In our institution, sedation is most often done by a propofol bolus of 2-5 mg/kg in order to reach a deep level of sedation as defined by Coté et al. If judged necessary by the attending anaesthesiologist, a additional propofol bolus of 0.5-1 mg/kg may be given. For longer lasting exams, the attending anaesthesiologist can chose to use a continuous infusion of propofol. The investigators will review the charts of 4 month of magnetic resonance imaging, which will give us a cohort of about 100 patients. Baseline characteristics, detailed sedation technique used will be recorded. Adverse events defined as: * Oxygen desaturation measured by transcutaneous oximetry SpO2≤94% * hypercapnia measure by end-tidal CO2 \>45 mm Hg * movement of the patient Assuming a non-normal distribution (tested by a Kolmogorov-Smirnov test), variables will be reported as median and interquartile range. Statistical tests will be done by non-parametric tests, Mann Whitney U. Non continuous variables will be analyzed by a Chi-square test.
Conditions
- Multiparametric Magnetic Resonance Imaging
- Propofol Adverse Reaction
- Sedation Complication
- Anesthesia; Adverse Effect
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propofol | Sedation by propofol |
Timeline
- Start date
- 2020-07-03
- Primary completion
- 2020-07-30
- Completion
- 2020-07-30
- First posted
- 2020-07-02
- Last updated
- 2020-08-26
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04455776. Inclusion in this directory is not an endorsement.